Lycebac Tablet contains Baclofen 10mg, a centrally acting skeletal muscle relaxant indicated for the management of spasticity resulting from conditions such as multiple sclerosis, spinal cord injuries, and other neurological disorders. Baclofen exerts its therapeutic effect by acting as a gamma-aminobutyric acid (GABA) agonist at GABA-B receptors in the central nervous system, leading to inhibition of monosynaptic and polysynaptic reflexes at the spinal level. This results in decreased muscle spasticity, improved muscle tone, and relief from associated pain and stiffness. Lycebac is typically administered orally, with dosage individualized based on patient response and clinical condition, starting at a low dose and gradually titrated to minimize adverse effects. Common side effects include drowsiness, dizziness, weakness, and gastrointestinal disturbances, which are generally dose-dependent and reversible upon discontinuation or dose adjustment. Caution is advised in patients with renal impairment, epilepsy, or history of hypersensitivity to Baclofen. Abrupt withdrawal should be avoided due to risk of withdrawal symptoms such as hallucinations, seizures, and rebound spasticity. Lycebac Tablet should be used under medical supervision, with regular monitoring to optimize therapeutic outcomes and ensure patient safety.